15
Views
19
CrossRef citations to date
0
Altmetric
Review

Current understanding of Baboon syndrome

Pages 163-175 | Published online: 10 Jan 2014

References

  • Andersen KE, Hjorth N, Menné T. The baboon syndrome: systemically-induced allergic contact dermatitis. Contact Derm.10(2), 97–100 (1984).
  • Nakayama H, Niki F, Shono M, Hada S. Mercury exanthem. Contact Derm.9(5), 411–417 (1983).
  • Menné T, Veien NK, Maibach HL. Systemic contact dermatitis. Am. J. Contact Derm.5(1), 1–12 (1994).
  • Lachapelle JM. The spectrum of diseases for which patch testing is recommended. Patients who should be investigated. In: Patch Testing/Prick Testing. A Practical Guide. Lachapelle JM, Maibach HI (Eds). Springer Verlag, Berlin, Germany 7–26 (2003).
  • Veien N, Menné T. Systemic contact dermatitis. In: Contact Dermatitis (4th Edition). Frosch PJ, Menné T, Lepoittevin J-P (Eds). Springer, Berlin, Germany 295–307 (2006).
  • Veien N, Menné T, Maibach HI. Systemic contact dermatitis. In: Marzulli and Maibach’s Dermatotoxicology (7th Edition). Zhai H, Wilhelm K-P, Maibach HI (Eds). CRC Press, Boca Raton, USA 139–153 (2008).
  • Bajaj AK, Saraswat A. Systemic contact dermatitis. Indian J. Dermatol. Venereol. Leprol.72(2), 99–102 (2006).
  • Jacob SE, Zapolanski T. Systemic contact dermatitis. Dermatitis19(1), 9–15 (2008).
  • Thyssen JP, Maibach HI. Drug-elicited systemic allergic (contact) dermatitis – update and possible pathomechanisms. Contact Derm.59(4), 195–202 (2008).
  • Pigatto PD, Guzzi G. Systemic allergic dermatitis syndrome caused by mercury. Contact Derm.59(1), 66 (2008).
  • Oh CK, Jo JH, Jang HS, Kim MB, Kwon YW, Kwon KS. An unusual case of mercurial baboon syndrome from metallic mercury in a broken industrial barometer. Contact Derm.49(6), 309–310 (2003).
  • Audicana M, Bernedo N, Gonzalez I, Muñoz D, Fernández E, Gastaminza G. An unusual case of baboon syndrome due to mercury present in a homeopathic medicine. Contact Derm.45(3), 185 (2001).
  • Bártolo E, Brandão FM. Mercury exanthem. Contact Derm.18(3), 172 (1988).
  • Rogers M, Goodhew P, Szafraniec T, McColl I. Mercury exanthem. Australas. J. Dermatol.27(2), 70–75 (1986).
  • Ozkaya E. An unusual case of mercurial baboon syndrome: lasting seasonal attacks in a retired metalworker. Contact Derm.58(2), 107–108 (2008).
  • Lerch M, Bircher AJ. Systemically induced allergic exanthem from mercury. Contact Derm.50(6), 349–353 (2004).
  • Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Derm.51(5–6), 297–310 (2004).
  • Goossens C, Sass U, Song M. Baboon syndrome. Dermatology194(4), 421–422 (1997).
  • Moreno-Ramírez D, García-Bravo B, Pichardo AR, Rubio FP, Martínez FC. Baboon syndrome in childhood: easy to avoid, easy to diagnose, but the problem continues. Pediatr. Dermatol.21(3), 250–253 (2004).
  • Morales Hernández J, Fleta Zaragozano J, Ayerza Casas A et al. [Baboon syndrome] An. Pediatr. (Barc.)68(5), 486–489 (2008).
  • Duve S, Worret W, Hofmann H. The baboon syndrome: a manifestation of haematogenous contact-type dermatitis. Acta Derm. Venereol.74(6), 480–481 (1994).
  • Wurpts G, Merk H. Baboon-Syndrom nach Einnahme von Amoxicillin. Hautarzt57(5), 452–454 (2006).
  • Isaksson M, Ljunggren B. Systemic contact dermatitis from ethylenediamine in an aminophylline preparation presenting as the baboon syndrome. Acta Derm. Venereol.83(1), 69–70 (2002).
  • Marques C, Faria E, Machado A, Gonçalo M, Gonçalo S. Allergic contact dermatitis and systemic contact dermatitis from cinchocaine. Contact Derm.33(6), 443 (1995).
  • Gordon E. Baboon syndrome caused by Salasate. J. Drugs. Dermatol.1(1), 66 (2002).
  • Herfs H, Schirren CG, Przybilla B, Plewig G. “Baboon syndrome”. A particular manifestation of hematogenous contact reaction. Hautarzt44(7), 466–469 (1993).
  • Wakelin SH, Sidhu S, Orton DI, Chia Y, Shaw S. Amoxycillin-induced flexural exanthem. Clin. Exp. Dermatol.24(2), 71–73 (1999).
  • Zimmer J, Grange F, Straub P, Haegy JM, Guillaume JC. Mercury erythema after accidental exposure to mercury vapor. Ann. Med. Interne (Paris)148(4), 317–320 (1997).
  • Jankowska-Konsur A, Kolodziej T, Szepietowski J, Sikora J, Maj J, Baran E. The baboon syndrome – report of two first cases in Poland. Contact Derm.52(5), 289–290 (2005).
  • Belhadjali H, Youssef M, Amri M, Douki W, Zili J. Atypical mercury exanthema. Contact Derm.58(2), 110–111 (2008).
  • Wolf R, Brenner S, Krakowski A. Intertriginous drug eruption. Acta Derm. Venereol.72(6), 441–442 (1992).
  • Wolf R, Orion E, Matz H. The baboon syndrome or intertriginous drug eruption: a report of eleven cases and a second look at its pathomechanism. Dermatol. Online J.9(3), 2 (2003).
  • Panhans-Gross A, Gall H, Peter R-U. Baboon syndrome after oral penicillin. Contact Derm.41(6), 352–353 (1999).
  • Vena GA, Foti C, Grandolfo M, Angelini G. Mercury exanthem. Contact Derm.31(4), 214–216 (1994).
  • Sans V, Jouary T, Hubiche T, Smith D, Milpied B, Taieb A. Baboon syndrome induced by cetuximab. Arch. Dermatol.144(2), 272–274 (2008).
  • Chowdhury MM, Patel GK, Inaloz HS, Holt PJ. Hydroxyurea-induced skin disease mimicking the baboon syndrome. Clin. Exp. Dermatol.24(4), 336–337 (1999).
  • Alegre M, Pujol RM, Alomar A. A generalized itchy flexural eruption in a 7-year-old boy. Arch. Dermatol.136(8), 1055–1060 (2000).
  • Montag G, Weber L, Gall H. Baboon-syndrom auf Allopurinol. Akt. Dermatol.22, 311–313 (1996).
  • Pfeiff B, Pullmann H. Baboon-artiges Arzneiexanthem auf heparin. Dtsch. Dermatologe39, 559–560 (1991).
  • Pigatto PD, Guzzi G, Persichini P, Barbadillo S. Recovery from mercury-induced burning mouth syndrome due to mercury allergy. Dermatitis15(2), 75–77 (2004).
  • Garcia-Bravo B, Repiso JB, Camacho F. Systemic contact dermatitis due to deflazacort. Contact Derm.43(6), 359–360 (2000).
  • Le Coz CJ, Boos V, Cribier BJ, Grosshans EM, Heid E. An unusual case of mercurial baboon syndrome. Contact Derm.35(2), 112 (1996).
  • Khelifa-Hamdani E, Touati-Serraj M, Perriard J, Chavaz P, Saurat JH, Kaya G. Giant cell lichenoid dermatitis in a patient with baboon syndrome. J. Cutan. Pathol.35(Suppl. 1), 17–19 (2008).
  • Sánchez TS, Sánchez-Pérez J, Aragüés M, García-Díaz A. Flare-up reaction of pseudoephedrine baboon syndrome positive patch test. Contact Derm.42(5), 312–313 (2000).
  • Barbaud A, Tréchot P, Granel F et al. A baboon syndrome induced by intravenous human immunoglobulins: report of a case and immunological analysis. Dermatology199(3), 258–260 (1999).
  • Arnold AW, Hausermann P, Bach S, Bircher AJ. Recurrent flexural exanthema (SDRIFE or baboon syndrome) after administration of two different iodinated radio contrast media. Dermatology214(1), 89–93 (2007).
  • García-Menaya JM, Cordobés-Durán C, Bobadilla P, Lamilla A, Moreno I. Baboon syndrome: 2 simultaneous cases in the same family. Contact Derm.58(2), 108–109 (2008).
  • Sato K, Kusaka Y, Zhang Q et al. Investigation of the association between mercury sensitization and HLA-DR6. Contact Derm.34(4), 295 (1996).
  • Pigatto PD, Mazzi B, Fleischhauer K, Guzzi G. Linking allergy to mercury to HLA and burning mouth syndrome. J. Eur. Acad. Dermatol. Venereol.21(8), 1118–1120 (2007).
  • Westphal GA, Schnuch A, Moessner R et al. Cytokine gene polymorphisms in allergic contact dermatitis. Contact Derm.48(2), 93–98 (2003).
  • Reich K, Westphal G, König IR et al. Association of allergic contact dermatitis with a promoter polymorphism in the IL16 gene. J. Allergy Clin. Immunol.112(6), 1191–1194 (2003).
  • Alfirevic A, Pirmohamed M. Adverse drug reactions and pharmacogenomics: recent advances. Per. Med.5(1), 11–23 (2008).
  • Pellicano R, Lomuto M, Ciavarella G, Di Giorgio G, Gasparini P. Fixed drug eruptions with feprazone are linked to HLA-B22. J. Am. Acad. Dermatol.36(5 Pt 1), 782–784 (1997).
  • Ozkaya E, Akar U. Fixed drug eruption induced by trimethoprim–sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype. J. Am. Acad. Dermatol.45(5), 712–717 (2001).
  • Hindsén M, Bruze M, Christensen OB. Flare-up reactions after oral challenge with nickel in relation to challenge dose and intensity and time of previous patch test reactions. J. Am. Acad. Dermatol.44(4), 616–623 (2001).
  • Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy59(8), 809–820 (2004).
  • Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions – new concepts. Clin. Exp. Allergy37(7), 989–999 (2007).
  • Weiss JM, Mockenhaupt M, Schöpf E, Simon JC. Fixes Arzneimittelexanthem auf Terbinafin mit charakteristischem Verteilungsmuster eines Baboon-Syndroms. Hautarzt52(12), 1104–1106 (2001).
  • Handisurya A, Stingl G, Wöhrl S. SDRIFE (baboon syndrome) induced by penicillin. Clin. Exp. Dermatol. (2008) (Epub ahead of print).
  • Yawalkar N, Pichler WJ. [Mechanisms of cutaneous drug reactions]. J. Dtsch. Dermatol. Ges.2(12), 1013–1023 (2004).
  • Stejskal VD, Forsbeck M, Cederbrant KE, Asteman O. Mercury-specific lymphocytes: an indication of mercury allergy in man. J. Clin. Immunol.16(1), 31–40 (1996).
  • Ozkaya E, Mirzoyeva L. Ötkür B. Mercury-induced systemic allergic dermatitis caused by ‘white precipitate’ in a skin lightening cream. Contact Derm.60(1), 61–63 (2009).
  • Barrazza V, Meunier P, Escande JP. Acute contact dermatitis and exanthematous pustulosis due to mercury. Contact Derm.38(6), 361 (1998).
  • Tschanz C, Prins C. Drug rash with eosinophilia and systemic symptoms caused by topical application of mercury. Dermatology201(4), 381–382 (2000).
  • Kolodziej T, Szepietowski JC, Sikora J, Bialynick-Birula R. The baboon syndrome due to nickel. Acta Dermatovenerol. Croat.11(1), 29–31 (2003).
  • Raison-Peyron N, Guillard O, Khalil Z, Guilhou JJ, Guillot B. Nickel-elicited systemic contact dermatitis from a peripheral intravenous catheter. Contact Derm.53(4), 222–225 (2005).
  • Kerosuo H, Kanerva L. Systemic contact dermatitis caused by nickel in a stainless steel orthodontic appliance. Contact Derm.36(2), 112–113 (1997).
  • Tanojo H, Hostynek JJ, Mountford HS, Maibach HI. In vivo permeation of nickel salts through human stratum corneum. Acta Derm. Venereol. Suppl. (Stockh.)212, 19–23 (2001).
  • Erdmann SM, Werfel T. Hämatogene Kontaktekzeme durch Nahrungsmittel. Hautarzt57(2), 116–120 (2006).
  • Salam TN, Fowler JF. Balsam-related systemic contact dermatitis. J. Am. Acad. Dermatol.45(3), 377–381 (2001).
  • Peitsch WK, Klemke C-D, Michel MS, Goerdt S, Bayerl C. Hämatogenes Kontaktekzem nach intravesikaler Instillation von Mitomycin C. Hautarzt58(3), 246–249 (2007).
  • Gallo R, Parodi A. Baboon syndrome from 5-aminosalicylic acid. Contact Derm.46(2), 110 (2002).
  • Proske S, Uter W, Schnuch A, Hartschuh W. Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the “baboon” syndrome. Dtsch. Med. Wochenschr.128(11), 545–547 (2003).
  • Erdmann SM, Sachs B, Merk HF. Systemic contact dermatitis from cinchocaine. Contact Derm.44(4), 260–261 (2001).
  • Pichler WJ, Beeler A, Keller M et al. Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol. Int.55(1), 17–25 (2006).
  • Schnyder B, Burkhart C, Schnyder-Frutig K et al. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J. Immunol.164(12), 6647–6654 (2000).
  • Treudler R, Simon JC. Symmetric, drug-related, intertriginous, and flexural exanthema in a patient with polyvalent intolerance to corticosteroids. J. Allergy Clin. Immunol.118(4), 965–967 (2006).
  • Lovejoy HB, Bell ZG, Vizena TR. Mercury exposure evaluations and their correlation with urine mercury excretion: 4. Elimination of mercury by sweating. J. Occup. Med.15(7), 590–591 (1973).
  • Ozkaya E. Fixed drug eruption: state of the art. J. Dtsch. Dermatol.6(3), 181–188 (2008).
  • Ozkaya E. Fixed drug eruption: primary site involvement on maximal points of Head’s zones. Acta Derm. Venereol.87(6), 517–520 (2007).
  • Faria A, de Freitas C. Systemic contact dermatitis due to mercury. Contact Derm.27(2), 110–111 (1992).
  • Fernandez L, Maquiera E, Garcia-Abujeta JL et al.Baboon syndrome due to mercury sensitivity. Contact Derm.33(1), 56–57 (1995).
  • Cha MK, Lee SC, Kim SY, Ha SJ, Lee GB. Two cases of the Baboon syndrome. Korean J. Allergy15(3), 354–358 (1995).
  • Suzuki K, Matsunaga K, Umemura Y, Ueda H, Sasaki K. Two cases of occupational dermatitis due to mercury vapor from a broken sphygmomanometer. Contact Derm.43(3), 175 (2000).
  • Descamps V, Lejoyeux F, Marck Y, Bouscarat F, Crickx B, Belaich S. Erysipelas-like mercury exanthema. Contact Derm.36(5), 277–278 (1997).
  • Bartolome B, Cordoba S, Sanchez-Perez J, Fernandez-Herrera J, Garcia-Diez A. Baboon syndrome of unusual origin. Contact Derm.43(2), 113 (2000).
  • Koch P, Nickolaus G. Allergic contact dermatitis and mercury exanthema due to mercury chloride in plastic boots. Contact Derm.34(6), 405–409 (1996).
  • Swinyer LJ. Allergic contact dermatitis from metallic mercury. Contact Derm.6(3), 226–227 (1980).
  • Nakada T, Higo N, Iijima M, Nakayama H, Maibach HI. Patch test materials for mercury allergic contact dermatitis. Contact Derm.36(5), 237–239 (1997).
  • Wen L, Yin J, Ma DL, Lanier B. Baboon syndrome induced by mercury – first case report in China. Contact Derm.56(6), 356–357 (2007).
  • Jensen CS, Menné T, Johansen JD. Systemic contact dermatitis after oral exposure to nickel: a review with a modified meta-analysis. Contact Derm.54(2), 79–86 (2006).
  • Yanagi T, Kodama K, Yoshihisa Y, Shimizu H, Shimizu T. Macrophage migration inhibitory factor in zinc-allergic systemic contact dermatitis. Cytokine35(5–6), 270–274 (2006).
  • Isaksson M, Ljunggren B. Systemic contact dermatitis from ethylenediamine in an aminophylline preparation presenting as the baboon syndrome. Acta Derm. Venereol.83(1), 69–70 (2003).
  • Guin JD, Fields P, Thomas KL. Baboon syndrome from i.v. aminophylline in a patient allergic to ethylenediamine. Contact Derm.40(3), 170–171 (1999).
  • Menné T, Weismann K. Hematogenous contact eczema following oral administration of neomycin. Hautarzt35(6), 319–320 (1984).
  • Lechner T, Grytzmann B, Baurle G. Hematogenous allergic contact dermatitis after oral administration of nystatin. Mykosen30(3), 143–146 (1987).
  • Armingaud P, Martin L, Wierzbicka E, Estève E. Baboon syndrome due to a polysensitization with corticosteroids. Ann. Dermatol. Venereol.132(8–9 Pt 1), 675–677 (2005).
  • Köhler LD, Schönlein K, Kautzky F, Vogt HJ. Diagnosis at first glance: the baboon syndrome. Int. J. Dermatol.35(7), 502–503 (1996).
  • Kick G, Przybilla B. Delayed prick test reaction identifies amoxicillin as elicitor of baboon syndrome. Contact Derm.43(6), 366–367 (2000).
  • Strub C, Bircher AJ. Exanthema with emphasis of body flexure points 10 hours after administration of amoxicillin, “baboon syndrome”. Praxis (Bern 1994)91(6), 232–234 (2002).
  • Schultz ES, Diepgen TL. Clinical characteristics and the causes of the baboon syndrome. Derm. Beruf Umwelt44, 266–269 (1996).
  • Rasmussen LP, Menné T. Systemic contact eczema – the baboon syndrome – in ampicillin allergy. Ugeskr. Laeger147(16), 1341–1342 (1985).
  • Sánchez-Morillas L, Reaño Martos M, Rodríguez Mosquera M, Iglesias Cadarso A, Pérez Pimiento A, Domínguez Lázaro AR. Baboon syndrome due to pseudoephedrine. Contact Derm.48(4), 234 (2003).
  • Wolf R, Elman M, Brenner S. Drug-induced ‘intertrigo’. Int. J. Dermatol.32(7), 515–516 (1993).
  • Amichai B, Grunwald MH. Baboon syndrome following oral roxithromycin. Clin. Exp. Dermatol.27(6), 523 (2002).
  • Helmbold P, Hegemann B, Dickert C, Marsch WC. Symmetric ptychotropic and nonpigmenting fixed drug eruption due to cimetidine (so-called baboon syndrome). Dermatology197(4), 402–403 (1998).
  • De Groot AC, Conemans JM. Systemic allergic contact dermatitis from intravesical instillation of the antitumor antibiotic mitomycin C. Contact Derm.24(3), 201–209 (1991).
  • Daito J, Hanada K, Katoh N et al. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir. Dermatology218(1), 60–62 (2009).
  • Dhingra B, Grover C. Baboon syndrome. Indian Pediatr.44(12), 937 (2007).
  • Ichimiya M, Hamamoto Y, Muto M. A case of baboon syndrome associated with group a streptococcal infection. J. Dermatol.30(1), 69–71 (2003).
  • Yamada Y, Iwasa A, Kuroki M, Yoshida M, Itoh M. Human parvovirus B19 infection showing follicular purpuric papules with a baboon syndrome-like distribution. Br. J. Dermatol.150(4), 788–789 (2004).
  • Barbaud A, Gonçalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Derm.45(6), 321–328 (2001).
  • Handley J, Todd D, Burrows D. Mercury allergy in a contact dermatitis clinic in Northern Ireland. Contact Derm.29(5), 258–261 (1993).
  • Kubo Y, Nonaka S, Yoshida H. False positive reaction to patch testing with aqueous mercuric chloride in an aluminum Finn Chamber®. Contact Derm.26(2), 136–137 (1992); erratum in: Contact Derm.27(2), 136 (1992).
  • Mellstróm GA, Wahlberg JE. Patch test preparations of mercury ammonium chloride under the microscope. Contact Derm.27(3), 193–194 (1992).
  • Wilkinson DS, Fregert S, Magnusson B et al. Terminology of contact dermatitis. Acta Derm. Venereol.50(4), 287–292 (1970).
  • Bruynzeel DP, Gonçalo M. Patch testing in adverse drug reactions. In: Contact Dermatitis (4th Edition). Frosch PJ, Menné T, Lepoittevin J-P (Eds). Springer, Berlin, Germany 401–412 (2006).
  • Aberer W, Bircher A, Romano A et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy58(9), 854–863 (2003).
  • Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology209(2), 209–216 (2005).
  • Romano A, Demoly P. Recent advances in the diagnosis of drug allergy. Curr. Opin. Allergy Clin. Immunol.7(4), 299–303 (2007).
  • Häusermann P, Bircher AJ. SDRIFE – another acronym for a distinct cutaneous drug exanthema: do we really need it? Dermatology214(1), 1–2 (2007).
  • Braun-Falco M, Kasche A, Worret WI. Recurring localized scarlatiniform scaled erythema Féréol-Besnier. Dermatology212(3), 253–257 (2006).
  • Audicana MT, Muñoz D, del Pozo MD, Fernández E, Gastaminza G, de Corres LF. Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal. Am. J. Contact Derm.13(1), 3–9 (2002).
  • Holubar K. Leopards, lions and wolves – a short visit to the zoo of dermatologic diagnoses. Wien. Klin. Wochenschr.117(9–10), 369–371 (2005).
  • Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther.30(2), 239–245 (1981).
  • Calkin JM, Maibach HI. Delayed hypersensitivity drug reactions diagnosed by patch testing. Contact Derm.29(5), 223–233 (1993).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.